Tożsamość

Larotrectinib Impurity 7

Nie podano · C21H22F2N6O5S

01Tożsamość

Lazychem IDLC-18174
CAS RNNie podano
PubChem CID164903155
Molecular formulaC21H22F2N6O5S
Molecular weight508.5 g/mol
IUPAC name(S)-1-((5-((R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)carbamoyl)pyrrolidin-3-yl hydrogen sulfate
InChIKeyPYKIHIHKZJWIBK-KBXCAEBGSA-N

02Struktura i stereochemia

2D structurePubChem CID 164903155
Two-dimensional chemical structure of Larotrectinib Impurity 7
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 2 defined stereocentres, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres2
Ring count5
Secondary amines0
Tertiary amines1
SMILESC1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)OS(=O)(=O)O)C5=C(C=CC(=C5)F)F
InChINie podano

03Stereochemistry

The published structure contains 2 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres2Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status w Indiach

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nazwy i powiązania

API i lek macierzysty

Larotrectinib

Zanieczyszczenia i związki pokrewne

Nazwy i powiązania

    Zanieczyszczenia i związki pokrewne

    06Źródła